A relationship between motilin and growth hormone secretagogue receptors

Hiroaki Nunoi1, Bunzo Matsuura, Sachiko Utsunomiya

  • 1Department of Gastroenterology & Metabology, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan.

Regulatory Peptides
|April 3, 2012
PubMed

Insights

The motilin receptor (MR) and growth hormone secretagogue receptor (GHSR) show a compensatory relationship. Motilin or erythromycin administration decreased acyl-ghrelin levels in MR transgenic mice, suggesting in vivo interaction.

Area of Science:

  • Molecular Pharmacology
  • G Protein-Coupled Receptors (GPCRs)
  • Endocrinology

Background:

  • The motilin receptor (MR) and growth hormone secretagogue receptor (GHSR) are Class I GPCRs with unclear structures and binding mechanisms.
  • Previous studies identified distinct regions in MR and GHSR important for binding natural and non-peptidyl ligands.
  • MR shares significant sequence identity with GHSR, particularly in transmembrane domains, suggesting potential functional overlap.

Purpose of the Study:

  • To investigate the relationship between MR and GHSR using chimeric constructs and co-expression systems.
  • To elucidate the in vivo relationship between motilin and ghrelin signaling pathways.
  • To understand the molecular basis of ligand binding and activation for MR and GHSR.

Main Methods:

  • Construction and functional analysis of MR-GHSR chimeric receptors in expression cells.
  • Co-expression of MR and GHSR in cells to assess combined functional responses.
  • Generation and administration of motilin and erythromycin to human MR transgenic mice to measure serum acyl-ghrelin levels and GI tract mRNA expression.

Main Results:

  • Chimeric receptor studies revealed specific domains responsible for ghrelin, erythromycin, and motilin binding.
  • Co-expression of MR and GHSR did not elicit additional ligand responses.
  • Administration of motilin or erythromycin to human MR transgenic mice significantly decreased serum acyl-ghrelin levels without altering MR and GHSR mRNA expression.

Conclusions:

  • The study delineates specific structural domains within MR and GHSR crucial for differential ligand recognition.
  • In vivo, motilin and ghrelin signaling pathways exhibit a compensatory relationship, where MR activation influences ghrelin levels.
  • These findings provide insights into the complex interplay between MR and GHSR in regulating physiological processes.

Related Concept Videos

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...